Intervention not reported
Chemotherapy toxicity · Adults with recurrent GBM
1 finding from 1 review
Intervention not reported
Overall survival median · Adults with recurrent HGG
The intervention showed no clear difference in overall survival median (moderate certainty).
1 finding from 1 review
Intervention not reported
PFS Median · Adults with recurrent HGG
The intervention showed no clear difference in PFS Median (moderate certainty).
1 finding from 1 review
Intervention not reported
QoL EORTC QoL questionnaire C30; at baseline, 12 weeks and 24 weeks · Adults with recurrent HGG
1 finding from 1 review
Intervention not reported
Chemotherapy toxicity During 1st 12 weeks of treatment · Adults with recurrent HGG
1 finding from 1 review
Intervention not reported
Development of carious lesions on sealed occlusal pits and fissures
The intervention led to lower development of carious lesions on sealed occlusal pits and fissures; GRADE not reported.
1 finding from 1 review
RD -0.07 [-0.14, -0.01]
2 studies
GRADE not reported
Intervention not reported
Mortality within the longest · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in mortality within the longest (low certainty).
1 finding from 1 review
Intervention not reported
Mortality within the longest · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
It is very uncertain whether the intervention changes mortality within the longest (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
1 finding from 1 review
Intervention not reported
Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
1 finding from 1 review
Intervention not reported
Surgical site infection within 30 days in trials with low risk of bias (14 days to 30 days) · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in surgical site infection within 30 days in trials with low risk of… (low certainty).
1 finding from 1 review
Intervention not reported
Surgical site infection within 30 days, irrespective of risk of bias (14 days to 30 days) · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in surgical site infection within 30 days, irrespective of risk of bias… (low certainty).
1 finding from 1 review
Intervention not reported
Respiratory insufficiency · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in respiratory insufficiency (moderate certainty).
1 finding from 1 review
Intervention not reported
Pain (at study completion) WOMAC (VAS or NRS) from 0 to 20; lower scores mean reduced pain · People with hip or knee osteoarthritis
1 finding from 1 review
Intervention not reported
Physical function (at study completion) WOMAC (self administered health status measure) from 0 to 68; lower scores mean better function · People with hip or knee osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse effects (related to the exercise programs) · People with hip or knee osteoarthritis
It is very uncertain whether the intervention changes adverse effects (related to the exercise programs) (very low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events or withdrawals (due to adverse events) ‐ not reported · People with hip or knee osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain ‐ duration exercise WOMAC (VAS or Likert) from 0 to 20 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Pain ‐ resistance exercise WOMAC (VAS or Likert) from 0 to 20 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Function ‐ duration exercise WOMAC from 0 to 68 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review